Search

Phreesia Inc

Gesloten

SectorGezondheidszorg

12.64 0.24

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

12.35

Max

12.84

Belangrijke statistieken

By Trading Economics

Inkomsten

-1M

1.9M

Verkoop

-1.5M

129M

K/W

Sectorgemiddelde

75.882

68.089

EPS

0.03

Winstmarge

1.482

Werknemers

1,789

EBITDA

4M

21M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+5.39% upside

Dividenden

By Acuity

Volgende Winsten

2 dec 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

46M

801M

Vorige openingsprijs

12.4

Vorige sluitingsprijs

12.64

Phreesia Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 nov 2026, 21:07 UTC

Phreesia, Inc. is experiencing a modest price increase, supported by significant gains in the Health Care Technology sub-sector, and is near the upper end of its one-month range.

12 nov 2026, 21:07 UTC

News

Bronstein, Gewirtz & Grossman, LLC is investigating Phreesia, Inc. for potential corporate wrongdoing by the company and its officers or directors.

11 nov 2026, 21:06 UTC

News

JPMorgan downgraded Phreesia, Inc. from Neutral to Underweight, citing concerns over strategic clarity and setting a price target of $13.00.

9 nov 2026, 20:46 UTC

Phreesia, Inc. shares are trading higher, reaching a notable peak around midday and remaining above its 20-day moving average since Friday's close.

6 nov 2026, 21:06 UTC

Phreesia, Inc. shares are declining, pulling back from earlier gains, and have faced a modest decline since Thursday's close.

5 nov 2026, 21:08 UTC

News

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing at Phreesia, Inc., raising governance concerns among investors.

4 nov 2026, 21:03 UTC

News

Phreesia, Inc. gains recognition as Vice President Sophia Wagner is named to Becker’s 2026 list of Health IT & Revenue Cycle Up-and-Comers.

2 nov 2026, 21:09 UTC

News

Phreesia, Inc. is trading modestly higher, benefiting from its acquisition of AccessOne and its ongoing transition to operating profitability.

23 okt 2026, 20:07 UTC

Phreesia Inc shares are declining amid a broader market downturn influenced by key economic indicators and concerns over rising oil prices.

22 okt 2026, 20:07 UTC

Phreesia Inc shares are advancing, reflecting the broader market's upward trend, marking five consecutive sessions of gains and trading significantly above its 20-day moving average.

21 okt 2026, 20:03 UTC

Phreesia Inc shares are advancing, continuing a trend of higher finishes, despite an earlier pullback from a session high amid broader market gains.

20 okt 2026, 20:01 UTC

Phreesia Inc shares are sharply higher, marking a divergence from the recent trend of higher daily closes observed since Monday's close.

16 okt 2026, 19:46 UTC

Phreesia Inc shares fell modestly after retracing from an earlier high.

15 okt 2026, 20:51 UTC

Phreesia Inc shares advanced in after-market trading, recovering from an initial slight loss to achieve a notable gain above the 20-day moving average.

12 okt 2026, 20:06 UTC

News

Barclays maintains Equal-Weight rating on Phreesia Inc and raises price target to $11, citing recent performance and market conditions.

8 okt 2026, 19:24 UTC

News

Michael Rasbury of Phreesia has been named to Becker’s Hospital Review’s 2026 list of Rising Stars in Healthcare, recognizing his contributions to patient financial engagement.

7 okt 2026, 20:07 UTC

Phreesia Inc is experiencing a higher trading session, continuing its upward trajectory since Tuesday, supported by strong performance in the health care technology sector.

29 sep 2026, 20:07 UTC

News

Phreesia, Inc. shares fell sharply as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing involving the company and its directors.

24 sep 2026, 20:07 UTC

Phreesia Inc. shares are advancing during Thursday's session, following an early spike that marked the stock's highest point shortly after the market opened.

23 sep 2026, 20:07 UTC

News

Phreesia Inc's stock is declining, reflecting investor concerns following the sale of 6.66k shares by General Counsel Hoffman Allison C on September 21, 2026.

8 sep 2026, 20:02 UTC

News

Phreesia Inc shares are lower after Raymond James downgraded the stock to Market Perform. An investigation by Bronstein, Gewirtz & Grossman, LLC adds to investor concerns.

4 sep 2026, 20:08 UTC

News

Phreesia Inc shares are lower as DA Davidson cuts its price target to $13.00 despite the company reporting a profitable quarter with $1.9 million net income.

3 sep 2026, 20:02 UTC

News

Phreesia Inc shares are lower after mixed Q2 results and an investigation announcement. RBC Capital maintained its "Outperform" rating and $19 price target.

2 sep 2026, 23:36 UTC

News

Phreesia shares declined after reporting second-quarter revenues of $129.5 million, while earnings per share of $0.03 missed expectations of $0.09.

28 aug 2026, 20:08 UTC

Phreesia Inc's shares are higher today, continuing a trend of gains over the past three sessions. No specific news was identified for the movement.

25 aug 2026, 19:16 UTC

News

Phreesia Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares during the session.

24 aug 2026, 19:46 UTC

Phreesia Inc shares are lower today amid broader market pressures from rising oil prices and geopolitical tensions, including new U.S. sanctions against Iran.

21 aug 2026, 19:36 UTC

Correlated Moves

Phreesia Inc is higher today, rebounding from an earlier dip. The stock reflects positive sentiment in health care technology amid rising yields.

20 aug 2026, 19:46 UTC

Phreesia Inc is trading higher as initial jobless claims fall below expectations, indicating strength in the labor market and supporting broader economic conditions.

19 aug 2026, 20:02 UTC

Correlated Moves

Phreesia Inc. shares are rising today, supported by gains in the ARK Genomic Revolution ETF and broader health care technology stocks.

Peer Vergelijking

Prijswijziging

Phreesia Inc Prognose

Koersdoel

By TipRanks

5.39% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 13.3 USD  5.39%

Hoogste 19 USD

Laagste 10 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Phreesia Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

12 ratings

6

Buy

5

Hold

1

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat